Development of Novel Dental Bone Graft and Substitutes Market- boost growth by Leading Players: Institut Straumann AG, Geistlich, DENTSPLY International, Zimmer Biomet, Medtronic Plc., BioHorizons IPH, Inc

Bone graft materials are available in varieties such as allografts, xenografts, and synthetic substitutes and can be custom made according to the need of the patient, which makes it convenient for both, the physician and patient driving the growth of the market. Bone grafts are widely available from various sources such as from patients, from another donor, from animal sources, or are synthetically made. Furthermore, advancements in technology has led to development of synthetic graft options with better stability, sterility, and long life.

Get a Request Sample of Research Report @ https://www.coherentmarketinsights.com/insight/request-sample/1187

Advancements have reduced surgical times along with post-operative pain and have improved healing time increasing adoption of these substitutes which has impacted the market. Development of biocompatible bone grafts such as B-OstiN and hydroxyapatite allografts and advent of different variants is a factor expected to fuel growth of the global dental bone graft substitutes market over the forecast period.

Continuous research and development in graft material along with improvement in bone grafting procedures are factors expected to aid in growth of the market. Manufacturers are focusing on launching new bone grafting products and related systems and accessories in order to cater to changing needs of the market. In 2015, NovaBone Product LLC received the U.S. Food & Drug Administration approval for launching minimally invasive bone graft system — NovaBone MacroFORM MIS delivery system — designed specifically for minimally invasive orthopedic procedures.

Request for Customization of Research Report @ https://www.coherentmarketinsights.com/insight/request-customization/1187

In January 2017, Citagenix, Inc. — subsidiary of Antibe Therapeutics Inc. — launched PentOS OI Max for oral and maxillofacial surgery. In 2016, Glidewell Laboratories launched a new line of dental bone grafting products under the brand, Newport Biologics. The line consists allograft and alloplast bone grafts. Furthermore, MIS Implant Technologies launched its bone graft cement 4MATRIX in 2016. The product was developed to simplify dental bone grafting procedures for dental prosthetic solutions and implants.

Dental bone grafting procedures are introduced to simplify surgical procedures and to reduce peri-operative and post-operative complications. For instance, in November 2017, a team of researchers from University of Minnesota introduced Continuous Periosteal Strapping Suture (CPSS) technique, which depends on resorbable sutures and membranes to maintain the integrity of the dental bone graft eliminating the requirement of an additional surgery for removal of tenting screws or tacks. Furthermore, research in bioactive glass for bone grafting is also aiding in growth of the market.

For instance, in 2016, engineers from Oregon State University (OSU) conducted research and reported potential effects of bioactive glass, which can reduce bacterial tendency of attacking tooth fillings. According to a study published in 2013, in Journal of Oral Implantology — an official publication of American Academy of Implant Dentistry — a new acellular dermis matrix (ADM) replacement material, decellularized dermis matrix (DDM) coupled with mineralized cancellous bone allograft (MCAB), can guide the regeneration of bone causing stable placement of the implant.

Inquire about Discount on this Report @ https://www.coherentmarketinsights.com/insight/request-discount/1187

Some major players operating in the dental bone graft and substitutes market are Institut Straumann AG, Geistlich, DENTSPLY International, Zimmer Biomet, Medtronic Plc., BioHorizons IPH, Inc., ACE Surgical Supply Company, Inc., RTI Surgical, Inc., LifeNet Health, and Citagenix

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

1001 4th Ave,, #3200, Seattle, WA 98154

This release was published on openPR.